Personalis Share Holder Equity 2018-2023 | PSNL
Personalis share holder equity from 2018 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Personalis Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$129 |
| 2022 |
$218 |
| 2021 |
$310 |
| 2020 |
$195 |
| 2019 |
$107 |
| 2018 |
$-106 |
| 2017 |
$0 |
Personalis Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$129 |
| 2023-09-30 |
$151 |
| 2023-06-30 |
$176 |
| 2023-03-31 |
$194 |
| 2022-12-31 |
$218 |
| 2022-09-30 |
$242 |
| 2022-06-30 |
$265 |
| 2022-03-31 |
$287 |
| 2021-12-31 |
$310 |
| 2021-09-30 |
$325 |
| 2021-06-30 |
$339 |
| 2021-03-31 |
$348 |
| 2020-12-31 |
$195 |
| 2020-09-30 |
$204 |
| 2020-06-30 |
$93 |
| 2020-03-31 |
$99 |
| 2019-12-31 |
$107 |
| 2019-09-30 |
$111 |
| 2019-06-30 |
$117 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
|
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| 2017-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.064B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
